Amryt Pharma

Distribution agreement for Lojuxta across CEE region

  • Sectors : Pharma and healthcare
  • Companies : Amryt Pharma

Ratings and price correct at time of issue.

  • Amryt Pharma

    Closing Price: 195.0p

  • RATING 14/09/17

  • PREVIOUS RATING N/A

DAVY VIEW

Amryt has announced a distribution agreement with Swixx Biopharma (Swixx), which will distribute Lojuxta across 17 jurisdictions in Central and Eastern Europe (CEE). Today’s announcement is indicative of the progress Amryt is making in its commercial efforts across EMEA, following the distribution agreement with Swixx signed in June 2020 for Metreleptin covering the CEE territories, and supports our growth forecasts which remain unchanged.

Download full report with analyst certification and important disclosures

Oct 19 2020, 08:15 IST/BST

Download